ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
50 announcements with these filters
Jubilant Ingrevia updated on a restructuring share subscription and purchase agreement closing in two tranches. First tranche is due by November 2026, second by September 2027.
Jubilant Ingrevia's subsidiary JAEL signed the SSPA for a 40% stake in Zettaone, with an option to reach 51%. The deal enters electronics design and manufacturing services.
Jubilant Ingrevia Limited filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing records the holdings of promoters, public shareholders and other categories.
Jubilant Ingrevia Employees Welfare Trust bought 45,000 shares on NSE for ₹2.49 Crore under its ESOP scheme. Post-trade holding rose to 0.98% of total equity.
Strong Q2 performance driven by volume growth across specialty chemicals and nutrition despite price softness in China.
Jubilant Ingrevia's Sr. Vice President & Head HR, Ms. Vinita Koul, resigned effective November 6, 2026. The departure is to pursue other interests.
Q2 FY27 revenue ₹1,394 Cr (+24% YoY), EBITDA ₹221 Cr (+51%, 16% margin), PAT ₹111 Cr (+61%). Pinnacle strategy continues; 40% ZettaOne stake (₹189.2 Cr) enters EDMS.
Jubilant Ingrevia board approved grant of 3,037 RSUs to eligible employees under its 2021 ESOP scheme. Vesting occurs at end of third year from grant date.
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,394 Cr (+24.4% YoY) and net profit of ₹111.4 Cr (+60.3% YoY) for Q2 FY27.
This is the quarterly shareholding pattern filing for Jubilant Ingrevia Ltd for the period ending September 30, 2026. It is a routine regulatory submission.
Jubilant Ingrevia Limited has scheduled a board meeting for October 27, 2026, to consider the unaudited standalone and consolidated financial results for the quarter.
Jubilant Ingrevia confirms incorporation of wholly-owned subsidiary Jubilant Advanced Electronics Limited on October 12, 2026. No capital or financial details are disclosed in this intimation.
Jubilant Ingrevia has filed a certificate confirming the utilization of proceeds from Commercial Paper issuances for working capital requirements for the quarter ended September 30, 2026.
Mr. Birajeev Singh, Senior Vice President - Supply Chain at Jubilant Ingrevia, has resigned effective November 5, 2026.
Jubilant Ingrevia has approved an amendment to its ESOP Plan 2021, increasing the stock option pool from 20 lakh to 30 lakh options. This remains subject to shareholder approval.
Jubilant Ingrevia Ltd will incorporate a new wholly owned subsidiary, Jubilant Advanced Electronics Limited, with an initial capital investment of up to ₹10 Crore.
Jubilant Ingrevia has issued Commercial Papers worth Rs. 100 Crore. This issuance, with a 90-day tenure, falls within the previously approved Rs. 600 Crore outstanding limit.
Jubilant Ingrevia Employees Welfare Trust sold 8,807 shares worth Rs.0.56 Crore. The sale was executed to facilitate the exercise of ESOP options.
Jubilant Ingrevia Employees Welfare Trust sold 2,587 equity shares worth Rs. 0.17 Crore on September 11, 2026.
Jubilant Ingrevia Employees Welfare Trust sold 5,622 equity shares for Rs. 0.38 Crore. The transfer was executed pursuant to the exercise of ESOPs.
Jubilant Ingrevia Ltd held its 7th AGM on August 26, 2026. All proposed resolutions, including dividend declaration and director appointments, were duly passed by members.
Jubilant Ingrevia Employees Welfare Trust sold 2,627 shares valued at ₹0.19 Crore, as disclosed in a regulatory filing under PIT Regulations.
Jubilant Ingrevia Ltd will acquire a 40% strategic stake in Zettaone Technologies for ₹189.2 Crore. This investment strengthens the company's presence in the electronics design and manufacturing space.
Jubilant Ingrevia informed shareholders with unregistered emails about accessing the Annual Report and AGM notice for FY 2025-26 via the company website.
Jubilant Ingrevia has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26 as per SEBI regulations.
Jubilant Ingrevia Ltd has scheduled its 7th Annual General Meeting for August 26, 2026. The meeting agenda includes dividend declaration and re-appointment of directors.
Jubilant Ingrevia reported a strong Q1 FY27 with revenue at a 15-quarter high of INR 1,300 Cr (up 25% YoY). Strategy focuses on the 'Pinnacle' journey, expanding CDMO and Specialty Chemical pipelines.
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,300 Cr (+25.2% YoY) and net profit of ₹106 Cr (+41.3% YoY) for Q1 FY27.
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,300 Cr (+25.3% YoY) and net profit of ₹105.8 Cr (+40.9% YoY) for Q1 FY27.
Jubilant Ingrevia has granted 42,298 stock options to eligible employees. These include both Restricted Stock Units and Performance Linked Stock Units.